This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.90% per year. These returns cover a period from January 1, 1988 through December 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
insurance: Archive
AXS Near 52-Week High: Time to Add the Stock for Better Returns?
by Zacks Equity Research
AXIS Capital gains from a well-performing specialty insurance, reinsurance, and the accident and health portfolio.
TRVPositive Net Change AXSPositive Net Change AFGPositive Net Change ACGLPositive Net Change
insurance
RDN Near 52-Week High: Time to Add the Stock for Better Returns?
by Zacks Equity Research
Radian Group stock is poised to gain from a growing insurance portfolio, declining claims, solid capital strength, and effective capital deployment.
METNegative Net Change PRUNegative Net Change AIZNegative Net Change RDNNegative Net Change
insurance
Top 4 Low-PEG Value Stocks Ready to Outperform the Market
by Urmimala Biswas
Here are four low-PEG value picks, ALL, TEF, ENS and CMC, as screens take into account strong growth potential and discounted valuations.
TEFPositive Net Change ALLPositive Net Change CMCNegative Net Change ENSNegative Net Change
basic-materials finance industrial-products insurance utilities
3 P&C Insurance Stocks That Have Outperformed the S&P 500 YTD
by Zacks Equity Research
Given the prospects of the Property and Casualty Insurance industry, HRTG, TRV, and HCI have the potential to generate better returns than other players.
TRVPositive Net Change HCIPositive Net Change HRTGPositive Net Change
insurance
Take the Zacks Approach to Beat the Markets: MBX Biosciences, Garrett Motion & Monster Beverage in Focus
by Santanu Roy
MBX Biosciences' sharp rally highlights how Zacks' stock recommendations outpaced broader market gains across multiple portfolios.
UNHNegative Net Change JNJPositive Net Change PWRPositive Net Change STXNegative Net Change AXSPositive Net Change CACIPositive Net Change CORNegative Net Change MNSTPositive Net Change COHRNegative Net Change NOBLNegative Net Change GTXNegative Net Change MBXPositive Net Change
auto-tires-trucks business-services computers construction consumer-staples insurance medical pharmaceuticals
5 Momentum Stocks to Buy for December After a Mixed November
by Nalak Das
December momentum picks gain traction as EXPE, ALL, DDS, KGC and GMED stand out after a mixed November.
DDSPositive Net Change ALLPositive Net Change EXPENegative Net Change KGCNegative Net Change GMEDNegative Net Change
gold insurance internet-content medical retail
Buy These 5 Best Value Stocks to Make the Most of P/B Ratio
by Kinjel Shah
Discover five low P/B picks like STNE that are undervalued and show solid growth potential based on value-focused filters.
AXSPositive Net Change GLDDNegative Net Change ENSNegative Net Change STNENegative Net Change KROSPositive Net Change
computers construction insurance pharmaceuticals
UNH Battles MCR, Optum Bandages: But the Real Wild Card is Washington
by Kaibalya Pravo Dey
UnitedHealth grapples with a surging MCR as Optum's strength steadies results while Washington's policy moves loom large.
UNHNegative Net Change CNCPositive Net Change ELVNegative Net Change
insurance medical
How Does BRK.B's SG&A Expense Management Impact Its Profits?
by Tanuka De
BRK.B keeps SG&A in check across its diverse businesses, but its real profit drivers are its insurance business and capital deployment.
BRK.BNegative Net Change ALLPositive Net Change PGRPositive Net Change
insurance
PRU Stock Trading at Discount to Industry at 7.28X: Time to Hold?
by Zacks Equity Research
Prudential Financial gains from solid asset-based businesses, strong demand for retirement products and global expansion.
CNONegative Net Change PRUNegative Net Change AIZNegative Net Change ACTNegative Net Change
insurance
MGIC Investment Trades Near 52-Week High: Time to Hold the Stock?
by Zacks Equity Research
MTG gains from strong new business, healthier housing activity, declining claims, and robust capital.
MTGNegative Net Change AIZNegative Net Change RDNNegative Net Change HMNNegative Net Change
insurance
Battle of Benefits: Will UNH Deliver the Bigger Dose or CVS? (Revised)
by Rajshree Sipani
CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.
UNHNegative Net Change CVSPositive Net Change
healthcare hmo insurance medical smart-health
BRK.B Stock Outperforms Industry, Trades at a Premium: Should You Buy?
by Tanuka De
BRK.B trades at a premium with mixed earnings signals and modest returns, despite outperforming its industry YTD.
CBNegative Net Change BRK.BNegative Net Change PGRPositive Net Change
insurance
Battle of Benefits: Will UNH Deliver the Bigger Dose or CVH?
by Rajshree Sipani
CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.
UNHNegative Net Change CVSPositive Net Change
healthcare hmo insurance medical smart-health
5 Women-Run Companies Reshaping Portfolios With Consistent Growth
by Shrabana Mukherjee
GM, SPGI, RL, M and GAP show how women-led companies are redefining growth with discipline, agility and results.
MNegative Net Change RLNegative Net Change PGRPositive Net Change GMNegative Net Change GAPNegative Net Change SPGIPositive Net Change
autonomous-vehicles finance insurance
New Strong Buy Stocks for Nov. 26: JRVR, CMC, and More
by Zacks Equity Research
WTBA, JRVR, CMC, PAAS and AEM have been added to the Zacks Rank #1 (Strong Buy) List on Nov. 26, 2025.
AEMNegative Net Change CMCNegative Net Change WTBANegative Net Change PAASNegative Net Change JRVRPositive Net Change
finance insurance precious-metals
Here's How BH Primary Group Fuels BRK.B's Insurance Operations
by Tanuka De
Berkshire Hathaway's insurance strength gets a steady boost from Berkshire Hathaway Primary Group???s durable, diversified underwriting engine.
TRVPositive Net Change CBNegative Net Change BRK.BNegative Net Change
insurance
PGR's Net Margin Shows Improvement: Can it Retain the Momentum?
by Tanuka De
Progressive's net margin gains, tech-driven underwriting and planned rate hikes raise the question of whether momentum can continue.
CBNegative Net Change BRK.BNegative Net Change PGRPositive Net Change
insurance
Steady Reward: Is Marsh & McLennan a Keeper or Just Comfortable?
by Zacks Equity Research
MMC leans on consulting strength, rising estimates and steady cash flow as it targets continued growth.
AIZNegative Net Change MMCNegative Net Change PRINegative Net Change SPNTNegative Net Change
finance insurance
Progressive's October Earnings Rise: Here's How to Play the Stock
by Tanuka De
PGR's October surge in EPS, revenues and policy growth highlights strengthening momentum despite recent share underperformance.
TRVPositive Net Change ALLPositive Net Change PGRPositive Net Change
insurance
Arch Capital Trades Above 50-Day SMA: Time to Buy ACGL Stock?
by Zacks Equity Research
ACGL is poised to gain from new business opportunities, rate increases, solid premium growth and effective capital deployment.
ACGLPositive Net Change KNSLNegative Net Change SKWDNegative Net Change
insurance
CNA Stock Trading at a Discount to Industry at 1.11X: Time to Buy?
by Zacks Equity Research
CNA Financial is poised to gain from solid retention, favorable renewal premium change and new business growth across Specialty, Commercial and International segments.
RNRPositive Net Change AXSPositive Net Change CNAPositive Net Change NMIHNegative Net Change
insurance
Zacks.com featured highlights include Phibro Animal Health, Astronics, CommScope and Heritage Insurance
by Zacks Equity Research
Phibro stands out as momentum builds across four stocks hitting 52-week highs and signaling potential for further gains.
ATRONegative Net Change COMMNegative Net Change PAHCNegative Net Change HRTGPositive Net Change
insurance
Four PEG-Driven GARP Winners for the Uncertainty of November 2025
by Urmimala Biswas
Four PEG-driven GARP picks emerge as compelling options amid market turmoil, with ALL, SANM, PAHC and ENS highlighted for their strong growth metrics.
ALLPositive Net Change SANMNegative Net Change ENSNegative Net Change PAHCNegative Net Change
finance industrial-products insurance medical medical-devices tech-stocks
Primerica Reloads Buyback Canon With a Fresh $475M Program
by Zacks Equity Research
PRI boosts shareholder returns with a new $475M buyback as strong Term Life momentum and solid liquidity support continued capital generation.
LNCNegative Net Change HIGNegative Net Change PRINegative Net Change
finance insurance